Medicines Co. (MDCO) Tops Q3 EPS by 6c

November 3, 2015 7:12 AM EST

Medicines Co. (NASDAQ: MDCO) reported Q3 EPS of ($0.82), $0.06 better than the analyst estimate of ($0.88). Revenue for the quarter came in at $72.7 million versus the consensus estimate of $68.58 million.

For earnings history and earnings-related data on Medicines Co. (MDCO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings